Enhancing Cardiovascular Dynamics by Inhibition of Thrombospondin- 1/CD47 Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|10|833-841

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.10, 2008-10, pp. : 833-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD47 in the Immune Response: Role of Thrombospondin and SIRP- Reverse Signaling

By  

Current Drug Targets, Vol. 9, Iss. 10, 2008-10 ,pp. : 842-850

Bentham Science Publishers

Access to resources Recommend Favorite

Methylmercury-Induced Inhibition of Paraoxonase-1 (PON1)—Implications for Cardiovascular Risk

By        

Journal of Toxicology and Environmental Health, Vol. 77, Iss. 17, 2014-09 ,pp. : 1004-1023

Taylor & Francis Ltd

Access to resources Recommend Favorite

Regulation of Thrombospondin1 by Extracellular Proteases

By  

Current Drug Targets, Vol. 9, Iss. 10, 2008-10 ,pp. : 863-868

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4899-4905

Bentham Science Publishers

Access to resources Recommend Favorite

Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 23, Iss. 10, 2016-03 ,pp. : 983-999

Bentham Science Publishers

Access to resources Recommend Favorite